References
- Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, et al. Melioidosis: a major cause of community-acquired septicaemia in northeastern Thailand. J Infect Dis 1989;159:890–9.
- Puthucheary SD, Parasakthi N, Lee MK. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg 1992;86: 683–5.
- Heng BH, Goh KT, Yap EH, Loh H, Yeo M. Epidemiological surveillance of melioidosis in Singapore. Ann Acad Med Singapore 1998;27:478–84.
- Wong KT, Puthucheary SD, Vadivelu J. The histopathology of human melioidosis. Histopathology 1995;26:51–5.
- Ashdown LR. An improved technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 1979;11:293–7.
- Dance DAB, Wuthiekanun V, Chaowagul W, White NJ. The antimicrobial susceptibility of Pseudomonas pseudomallei: emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989;24:295–309.
- Jenny AW, Lum G, Fisher DA, Curry BJ. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001;17:109–13.
- White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;2:697–701.
- Sookpranee M, Boonma P, Susaengrat W, Bhuripanyo K, Punyagupta S. Multicentre prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycyline and co-trimoxazole for treatment of severe melioidosis. Antimicrob Agents Chemother 1992;36: 158–62.
- White NJ. Melioidosis. Lancet 2003;361:1715–22.